Zoe Crane-Smith
Overview
Explore the profile of Zoe Crane-Smith including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
44
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maniou E, Farah F, Marshall A, Crane-Smith Z, Krstevski A, Stathopoulou A, et al.
Development
. 2023 Sep;
150(19).
PMID: 37756583
Closed spinal dysraphisms are poorly understood malformations classified as neural tube (NT) defects. Several, including terminal myelocystocele, affect the distal spine. We have previously identified a NT closure-initiating point, Closure...
2.
Crane-Smith Z, de Castro S, Nikolopoulou E, Wolujewicz P, Smedley D, Lei Y, et al.
Hum Mol Genet
. 2023 Jun;
32(17):2681-2692.
PMID: 37364051
Orofacial clefts, including cleft lip and palate (CL/P) and neural tube defects (NTDs) are among the most common congenital anomalies, but knowledge of the genetic basis of these conditions remains...
3.
Wilkinson E, Brennan L, Harrison O, Crane-Smith Z, Gautier P, Keighren M, et al.
Pigment Cell Melanoma Res
. 2022 Nov;
36(1):71-77.
PMID: 36412082
Genetic approaches that allow lineage tracing are essential to our future understanding of melanocytes and melanoma. To date, the approaches used to label melanocytes in mice have relied on random...
4.
Crane-Smith Z, Schoenebeck J, Graham K, Devenney P, Rose L, Ditzell M, et al.
Front Cell Dev Biol
. 2021 Apr;
9:595744.
PMID: 33869166
Enhancers that are conserved deep in evolutionary time regulate characteristics held in common across taxonomic classes. Here, deletion of the highly conserved enhancer SBE2 ( brain enhancer 2) in mouse...
5.
Neill T, Jones H, Crane-Smith Z, Owens R, Schaefer L, Iozzo R
FEBS J
. 2013 Jan;
280(10):2353-68.
PMID: 23350987
Pathological neovascularization relies on an imbalance between potent proangiogenic agents and equally effective antiangiogenic cues. Collectively, these factors contribute to an angiogenic niche within the tumor microenvironment. Oncogenic events and...